nodes	percent_of_prediction	percent_of_DWPC	metapath
Albendazole—TUBB4B—Vincristine—sarcoma	0.369	0.438	CbGbCtD
Albendazole—CYP1A1—Dacarbazine—sarcoma	0.126	0.15	CbGbCtD
Albendazole—CYP1A2—Dacarbazine—sarcoma	0.0563	0.0668	CbGbCtD
Albendazole—CYP3A4—Thiotepa—sarcoma	0.0532	0.0631	CbGbCtD
Albendazole—ABCB1—Dactinomycin—sarcoma	0.0426	0.0506	CbGbCtD
Albendazole—ABCB1—Mitoxantrone—sarcoma	0.0382	0.0453	CbGbCtD
Albendazole—CYP1A2—Etoposide—sarcoma	0.0275	0.0327	CbGbCtD
Albendazole—ABCB1—Vincristine—sarcoma	0.0263	0.0312	CbGbCtD
Albendazole—ABCB1—Etoposide—sarcoma	0.0241	0.0286	CbGbCtD
Albendazole—CYP3A4—Mitoxantrone—sarcoma	0.0229	0.0271	CbGbCtD
Albendazole—ABCB1—Doxorubicin—sarcoma	0.0164	0.0195	CbGbCtD
Albendazole—CYP3A4—Vincristine—sarcoma	0.0157	0.0187	CbGbCtD
Albendazole—CYP3A4—Etoposide—sarcoma	0.0144	0.0171	CbGbCtD
Albendazole—CYP3A4—Doxorubicin—sarcoma	0.00984	0.0117	CbGbCtD
Albendazole—Alopecia reversible—Etoposide—sarcoma	0.00597	0.0627	CcSEcCtD
Albendazole—TUBA1A—mammary gland—sarcoma	0.00381	0.061	CbGeAlD
Albendazole—Alopecia reversible—Epirubicin—sarcoma	0.00335	0.0351	CcSEcCtD
Albendazole—Alopecia reversible—Doxorubicin—sarcoma	0.0031	0.0325	CcSEcCtD
Albendazole—TUBA1A—myometrium—sarcoma	0.0027	0.0433	CbGeAlD
Albendazole—TUBA1A—embryo—sarcoma	0.0026	0.0416	CbGeAlD
Albendazole—TUBB4B—mammary gland—sarcoma	0.00254	0.0406	CbGeAlD
Albendazole—TUBA1A—seminal vesicle—sarcoma	0.00244	0.0391	CbGeAlD
Albendazole—TUBA1A—hematopoietic system—sarcoma	0.00232	0.0372	CbGeAlD
Albendazole—TUBA1A—connective tissue—sarcoma	0.00224	0.0358	CbGeAlD
Albendazole—TUBA1A—smooth muscle tissue—sarcoma	0.00205	0.0327	CbGeAlD
Albendazole—TUBA1A—skin of body—sarcoma	0.00202	0.0323	CbGeAlD
Albendazole—TUBB4B—myometrium—sarcoma	0.0018	0.0288	CbGeAlD
Albendazole—TUBA1A—cardiac atrium—sarcoma	0.00176	0.0282	CbGeAlD
Albendazole—Aplastic anaemia—Dactinomycin—sarcoma	0.00176	0.0185	CcSEcCtD
Albendazole—TUBA1A—uterus—sarcoma	0.00175	0.0281	CbGeAlD
Albendazole—TUBB4B—embryo—sarcoma	0.00173	0.0277	CbGeAlD
Albendazole—TUBA1A—lymphoid tissue—sarcoma	0.00163	0.0262	CbGeAlD
Albendazole—TUBB4B—seminal vesicle—sarcoma	0.00163	0.0261	CbGeAlD
Albendazole—TUBB4B—hematopoietic system—sarcoma	0.00155	0.0248	CbGeAlD
Albendazole—TUBA1A—tendon—sarcoma	0.00154	0.0246	CbGeAlD
Albendazole—TUBB4B—connective tissue—sarcoma	0.00149	0.0238	CbGeAlD
Albendazole—TUBA1A—bone marrow—sarcoma	0.00149	0.0238	CbGeAlD
Albendazole—TUBB4B—smooth muscle tissue—sarcoma	0.00136	0.0218	CbGeAlD
Albendazole—TUBB4B—skin of body—sarcoma	0.00135	0.0215	CbGeAlD
Albendazole—Renal failure acute—Mitoxantrone—sarcoma	0.00128	0.0135	CcSEcCtD
Albendazole—TUBA1A—testis—sarcoma	0.00127	0.0204	CbGeAlD
Albendazole—Liver function test abnormal—Dactinomycin—sarcoma	0.00126	0.0132	CcSEcCtD
Albendazole—TUBA1A—liver—sarcoma	0.0012	0.0192	CbGeAlD
Albendazole—TUBB4B—cardiac atrium—sarcoma	0.00118	0.0188	CbGeAlD
Albendazole—TUBB4B—uterus—sarcoma	0.00117	0.0187	CbGeAlD
Albendazole—Pancytopenia—Thiotepa—sarcoma	0.00112	0.0118	CcSEcCtD
Albendazole—Pancytopenia—Dactinomycin—sarcoma	0.00112	0.0117	CcSEcCtD
Albendazole—Neutropenia—Dactinomycin—sarcoma	0.0011	0.0115	CcSEcCtD
Albendazole—TUBB4B—lymphoid tissue—sarcoma	0.00109	0.0174	CbGeAlD
Albendazole—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00104	0.0109	CcSEcCtD
Albendazole—TUBB4B—tendon—sarcoma	0.00102	0.0164	CbGeAlD
Albendazole—Hepatobiliary disease—Thiotepa—sarcoma	0.000998	0.0105	CcSEcCtD
Albendazole—Pancytopenia—Vincristine—sarcoma	0.000997	0.0105	CcSEcCtD
Albendazole—TUBB4B—bone marrow—sarcoma	0.000992	0.0159	CbGeAlD
Albendazole—Agranulocytosis—Thiotepa—sarcoma	0.000985	0.0103	CcSEcCtD
Albendazole—Neutropenia—Vincristine—sarcoma	0.000982	0.0103	CcSEcCtD
Albendazole—Agranulocytosis—Dactinomycin—sarcoma	0.000978	0.0103	CcSEcCtD
Albendazole—Pancytopenia—Mitoxantrone—sarcoma	0.000971	0.0102	CcSEcCtD
Albendazole—Neutropenia—Mitoxantrone—sarcoma	0.000956	0.01	CcSEcCtD
Albendazole—Hepatitis—Dactinomycin—sarcoma	0.00094	0.00988	CcSEcCtD
Albendazole—Urinary tract disorder—Thiotepa—sarcoma	0.000936	0.00983	CcSEcCtD
Albendazole—Urethral disorder—Thiotepa—sarcoma	0.000929	0.00976	CcSEcCtD
Albendazole—TUBA1A—lymph node—sarcoma	0.000922	0.0148	CbGeAlD
Albendazole—Erythema multiforme—Dactinomycin—sarcoma	0.000889	0.00934	CcSEcCtD
Albendazole—CYP1A2—hematopoietic system—sarcoma	0.000878	0.0141	CbGeAlD
Albendazole—CYP1A1—hematopoietic system—sarcoma	0.000867	0.0139	CbGeAlD
Albendazole—Immune system disorder—Thiotepa—sarcoma	0.000856	0.00899	CcSEcCtD
Albendazole—Agranulocytosis—Mitoxantrone—sarcoma	0.000851	0.00893	CcSEcCtD
Albendazole—TUBB4B—testis—sarcoma	0.000848	0.0136	CbGeAlD
Albendazole—Alopecia—Thiotepa—sarcoma	0.000837	0.00879	CcSEcCtD
Albendazole—Alopecia—Dactinomycin—sarcoma	0.000831	0.00873	CcSEcCtD
Albendazole—Urinary tract disorder—Vincristine—sarcoma	0.00083	0.00871	CcSEcCtD
Albendazole—Urethral disorder—Vincristine—sarcoma	0.000824	0.00865	CcSEcCtD
Albendazole—Hepatitis—Mitoxantrone—sarcoma	0.000818	0.00859	CcSEcCtD
Albendazole—Pancytopenia—Etoposide—sarcoma	0.000808	0.00848	CcSEcCtD
Albendazole—TUBB4B—liver—sarcoma	0.000802	0.0128	CbGeAlD
Albendazole—Neutropenia—Etoposide—sarcoma	0.000795	0.00835	CcSEcCtD
Albendazole—CYP1A1—skin of body—sarcoma	0.000753	0.0121	CbGeAlD
Albendazole—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000752	0.00789	CcSEcCtD
Albendazole—Alopecia—Vincristine—sarcoma	0.000743	0.0078	CcSEcCtD
Albendazole—Leukopenia—Thiotepa—sarcoma	0.000738	0.00775	CcSEcCtD
Albendazole—Leukopenia—Dactinomycin—sarcoma	0.000733	0.0077	CcSEcCtD
Albendazole—Alopecia—Mitoxantrone—sarcoma	0.000723	0.00759	CcSEcCtD
Albendazole—Hepatobiliary disease—Etoposide—sarcoma	0.000717	0.00753	CcSEcCtD
Albendazole—Aplastic anaemia—Epirubicin—sarcoma	0.000713	0.00749	CcSEcCtD
Albendazole—Agranulocytosis—Etoposide—sarcoma	0.000708	0.00743	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000697	0.00732	CcSEcCtD
Albendazole—Urinary tract disorder—Etoposide—sarcoma	0.000672	0.00706	CcSEcCtD
Albendazole—Urethral disorder—Etoposide—sarcoma	0.000667	0.00701	CcSEcCtD
Albendazole—Aplastic anaemia—Doxorubicin—sarcoma	0.00066	0.00693	CcSEcCtD
Albendazole—Thrombocytopenia—Thiotepa—sarcoma	0.000659	0.00692	CcSEcCtD
Albendazole—CYP1A1—cardiac atrium—sarcoma	0.000658	0.0105	CbGeAlD
Albendazole—Vertigo—Vincristine—sarcoma	0.000657	0.0069	CcSEcCtD
Albendazole—Leukopenia—Vincristine—sarcoma	0.000655	0.00688	CcSEcCtD
Albendazole—CYP1A1—uterus—sarcoma	0.000655	0.0105	CbGeAlD
Albendazole—Thrombocytopenia—Dactinomycin—sarcoma	0.000654	0.00687	CcSEcCtD
Albendazole—Skin disorder—Thiotepa—sarcoma	0.000654	0.00687	CcSEcCtD
Albendazole—Erythema multiforme—Etoposide—sarcoma	0.000644	0.00676	CcSEcCtD
Albendazole—Leukopenia—Mitoxantrone—sarcoma	0.000638	0.0067	CcSEcCtD
Albendazole—CYP3A4—hematopoietic system—sarcoma	0.000636	0.0102	CbGeAlD
Albendazole—Immune system disorder—Etoposide—sarcoma	0.000615	0.00646	CcSEcCtD
Albendazole—TUBB4B—lymph node—sarcoma	0.000615	0.00984	CbGeAlD
Albendazole—Alopecia—Etoposide—sarcoma	0.000601	0.00632	CcSEcCtD
Albendazole—Renal failure acute—Epirubicin—sarcoma	0.000597	0.00627	CcSEcCtD
Albendazole—Thrombocytopenia—Vincristine—sarcoma	0.000584	0.00614	CcSEcCtD
Albendazole—Thrombocytopenia—Mitoxantrone—sarcoma	0.000569	0.00598	CcSEcCtD
Albendazole—Skin disorder—Mitoxantrone—sarcoma	0.000565	0.00593	CcSEcCtD
Albendazole—Renal failure acute—Doxorubicin—sarcoma	0.000553	0.0058	CcSEcCtD
Albendazole—Gastrointestinal pain—Thiotepa—sarcoma	0.000551	0.00578	CcSEcCtD
Albendazole—Gastrointestinal pain—Dactinomycin—sarcoma	0.000546	0.00574	CcSEcCtD
Albendazole—Urticaria—Thiotepa—sarcoma	0.000535	0.00562	CcSEcCtD
Albendazole—Vertigo—Etoposide—sarcoma	0.000532	0.00559	CcSEcCtD
Albendazole—Abdominal pain—Thiotepa—sarcoma	0.000532	0.00559	CcSEcCtD
Albendazole—Body temperature increased—Thiotepa—sarcoma	0.000532	0.00559	CcSEcCtD
Albendazole—Leukopenia—Etoposide—sarcoma	0.00053	0.00557	CcSEcCtD
Albendazole—Abdominal pain—Dactinomycin—sarcoma	0.000528	0.00555	CcSEcCtD
Albendazole—Body temperature increased—Dactinomycin—sarcoma	0.000528	0.00555	CcSEcCtD
Albendazole—ABCB1—myometrium—sarcoma	0.000524	0.00839	CbGeAlD
Albendazole—Liver function test abnormal—Epirubicin—sarcoma	0.000509	0.00535	CcSEcCtD
Albendazole—ABCB1—embryo—sarcoma	0.000504	0.00807	CbGeAlD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000501	0.00526	CcSEcCtD
Albendazole—Hypersensitivity—Thiotepa—sarcoma	0.000496	0.00521	CcSEcCtD
Albendazole—Hypersensitivity—Dactinomycin—sarcoma	0.000492	0.00517	CcSEcCtD
Albendazole—Gastrointestinal pain—Vincristine—sarcoma	0.000488	0.00513	CcSEcCtD
Albendazole—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000475	0.00499	CcSEcCtD
Albendazole—ABCB1—seminal vesicle—sarcoma	0.000474	0.00758	CbGeAlD
Albendazole—Thrombocytopenia—Etoposide—sarcoma	0.000473	0.00497	CcSEcCtD
Albendazole—Abdominal pain—Vincristine—sarcoma	0.000472	0.00496	CcSEcCtD
Albendazole—Body temperature increased—Vincristine—sarcoma	0.000472	0.00496	CcSEcCtD
Albendazole—Liver function test abnormal—Doxorubicin—sarcoma	0.000471	0.00495	CcSEcCtD
Albendazole—Skin disorder—Etoposide—sarcoma	0.00047	0.00493	CcSEcCtD
Albendazole—Urticaria—Mitoxantrone—sarcoma	0.000462	0.00485	CcSEcCtD
Albendazole—Abdominal pain—Mitoxantrone—sarcoma	0.00046	0.00483	CcSEcCtD
Albendazole—Body temperature increased—Mitoxantrone—sarcoma	0.00046	0.00483	CcSEcCtD
Albendazole—CYP1A2—liver—sarcoma	0.000455	0.00728	CbGeAlD
Albendazole—Pancytopenia—Epirubicin—sarcoma	0.000453	0.00475	CcSEcCtD
Albendazole—ABCB1—hematopoietic system—sarcoma	0.00045	0.0072	CbGeAlD
Albendazole—CYP1A1—liver—sarcoma	0.000449	0.00718	CbGeAlD
Albendazole—Neutropenia—Epirubicin—sarcoma	0.000446	0.00468	CcSEcCtD
Albendazole—Dizziness—Thiotepa—sarcoma	0.000445	0.00468	CcSEcCtD
Albendazole—Hypersensitivity—Vincristine—sarcoma	0.00044	0.00462	CcSEcCtD
Albendazole—Hypersensitivity—Mitoxantrone—sarcoma	0.000428	0.0045	CcSEcCtD
Albendazole—Vomiting—Thiotepa—sarcoma	0.000428	0.0045	CcSEcCtD
Albendazole—Vomiting—Dactinomycin—sarcoma	0.000425	0.00446	CcSEcCtD
Albendazole—Rash—Thiotepa—sarcoma	0.000424	0.00446	CcSEcCtD
Albendazole—Dermatitis—Thiotepa—sarcoma	0.000424	0.00445	CcSEcCtD
Albendazole—Headache—Thiotepa—sarcoma	0.000422	0.00443	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000421	0.00443	CcSEcCtD
Albendazole—Rash—Dactinomycin—sarcoma	0.000421	0.00442	CcSEcCtD
Albendazole—Pancytopenia—Doxorubicin—sarcoma	0.000419	0.0044	CcSEcCtD
Albendazole—Neutropenia—Doxorubicin—sarcoma	0.000412	0.00433	CcSEcCtD
Albendazole—Hepatobiliary disease—Epirubicin—sarcoma	0.000402	0.00422	CcSEcCtD
Albendazole—Nausea—Thiotepa—sarcoma	0.0004	0.0042	CcSEcCtD
Albendazole—Nausea—Dactinomycin—sarcoma	0.000397	0.00417	CcSEcCtD
Albendazole—Agranulocytosis—Epirubicin—sarcoma	0.000397	0.00417	CcSEcCtD
Albendazole—Gastrointestinal pain—Etoposide—sarcoma	0.000395	0.00415	CcSEcCtD
Albendazole—Dizziness—Vincristine—sarcoma	0.000395	0.00415	CcSEcCtD
Albendazole—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00039	0.00409	CcSEcCtD
Albendazole—Urticaria—Etoposide—sarcoma	0.000384	0.00403	CcSEcCtD
Albendazole—Body temperature increased—Etoposide—sarcoma	0.000382	0.00401	CcSEcCtD
Albendazole—Abdominal pain—Etoposide—sarcoma	0.000382	0.00401	CcSEcCtD
Albendazole—Hepatitis—Epirubicin—sarcoma	0.000382	0.00401	CcSEcCtD
Albendazole—Vomiting—Vincristine—sarcoma	0.00038	0.00399	CcSEcCtD
Albendazole—Urinary tract disorder—Epirubicin—sarcoma	0.000377	0.00396	CcSEcCtD
Albendazole—Rash—Vincristine—sarcoma	0.000376	0.00395	CcSEcCtD
Albendazole—Dermatitis—Vincristine—sarcoma	0.000376	0.00395	CcSEcCtD
Albendazole—Urethral disorder—Epirubicin—sarcoma	0.000374	0.00393	CcSEcCtD
Albendazole—Headache—Vincristine—sarcoma	0.000374	0.00393	CcSEcCtD
Albendazole—Hepatobiliary disease—Doxorubicin—sarcoma	0.000372	0.00391	CcSEcCtD
Albendazole—Vomiting—Mitoxantrone—sarcoma	0.00037	0.00388	CcSEcCtD
Albendazole—Agranulocytosis—Doxorubicin—sarcoma	0.000367	0.00385	CcSEcCtD
Albendazole—Rash—Mitoxantrone—sarcoma	0.000367	0.00385	CcSEcCtD
Albendazole—Dermatitis—Mitoxantrone—sarcoma	0.000366	0.00385	CcSEcCtD
Albendazole—Headache—Mitoxantrone—sarcoma	0.000364	0.00382	CcSEcCtD
Albendazole—Erythema multiforme—Epirubicin—sarcoma	0.000361	0.00379	CcSEcCtD
Albendazole—Hypersensitivity—Etoposide—sarcoma	0.000356	0.00374	CcSEcCtD
Albendazole—Nausea—Vincristine—sarcoma	0.000355	0.00372	CcSEcCtD
Albendazole—Hepatitis—Doxorubicin—sarcoma	0.000353	0.00371	CcSEcCtD
Albendazole—Urinary tract disorder—Doxorubicin—sarcoma	0.000349	0.00366	CcSEcCtD
Albendazole—Urethral disorder—Doxorubicin—sarcoma	0.000346	0.00363	CcSEcCtD
Albendazole—Nausea—Mitoxantrone—sarcoma	0.000345	0.00363	CcSEcCtD
Albendazole—Immune system disorder—Epirubicin—sarcoma	0.000345	0.00362	CcSEcCtD
Albendazole—CYP1A1—lymph node—sarcoma	0.000344	0.00551	CbGeAlD
Albendazole—ABCB1—uterus—sarcoma	0.00034	0.00544	CbGeAlD
Albendazole—Alopecia—Epirubicin—sarcoma	0.000337	0.00354	CcSEcCtD
Albendazole—Erythema multiforme—Doxorubicin—sarcoma	0.000334	0.00351	CcSEcCtD
Albendazole—CYP3A4—liver—sarcoma	0.000329	0.00527	CbGeAlD
Albendazole—Dizziness—Etoposide—sarcoma	0.00032	0.00336	CcSEcCtD
Albendazole—Immune system disorder—Doxorubicin—sarcoma	0.000319	0.00335	CcSEcCtD
Albendazole—ABCB1—lymphoid tissue—sarcoma	0.000317	0.00507	CbGeAlD
Albendazole—Alopecia—Doxorubicin—sarcoma	0.000312	0.00328	CcSEcCtD
Albendazole—Vomiting—Etoposide—sarcoma	0.000307	0.00323	CcSEcCtD
Albendazole—Rash—Etoposide—sarcoma	0.000305	0.0032	CcSEcCtD
Albendazole—Dermatitis—Etoposide—sarcoma	0.000305	0.0032	CcSEcCtD
Albendazole—Headache—Etoposide—sarcoma	0.000303	0.00318	CcSEcCtD
Albendazole—Vertigo—Epirubicin—sarcoma	0.000298	0.00313	CcSEcCtD
Albendazole—Leukopenia—Epirubicin—sarcoma	0.000297	0.00312	CcSEcCtD
Albendazole—ABCB1—bone marrow—sarcoma	0.000289	0.00462	CbGeAlD
Albendazole—Nausea—Etoposide—sarcoma	0.000287	0.00302	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000281	0.00295	CcSEcCtD
Albendazole—Vertigo—Doxorubicin—sarcoma	0.000276	0.0029	CcSEcCtD
Albendazole—Leukopenia—Doxorubicin—sarcoma	0.000275	0.00289	CcSEcCtD
Albendazole—Thrombocytopenia—Epirubicin—sarcoma	0.000265	0.00279	CcSEcCtD
Albendazole—Skin disorder—Epirubicin—sarcoma	0.000263	0.00277	CcSEcCtD
Albendazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00026	0.00273	CcSEcCtD
Albendazole—ABCB1—testis—sarcoma	0.000247	0.00395	CbGeAlD
Albendazole—Thrombocytopenia—Doxorubicin—sarcoma	0.000246	0.00258	CcSEcCtD
Albendazole—Skin disorder—Doxorubicin—sarcoma	0.000244	0.00256	CcSEcCtD
Albendazole—ABCB1—liver—sarcoma	0.000233	0.00373	CbGeAlD
Albendazole—Gastrointestinal pain—Epirubicin—sarcoma	0.000222	0.00233	CcSEcCtD
Albendazole—Urticaria—Epirubicin—sarcoma	0.000215	0.00226	CcSEcCtD
Albendazole—Abdominal pain—Epirubicin—sarcoma	0.000214	0.00225	CcSEcCtD
Albendazole—Body temperature increased—Epirubicin—sarcoma	0.000214	0.00225	CcSEcCtD
Albendazole—Gastrointestinal pain—Doxorubicin—sarcoma	0.000205	0.00215	CcSEcCtD
Albendazole—Hypersensitivity—Epirubicin—sarcoma	0.0002	0.0021	CcSEcCtD
Albendazole—Urticaria—Doxorubicin—sarcoma	0.000199	0.00209	CcSEcCtD
Albendazole—Abdominal pain—Doxorubicin—sarcoma	0.000198	0.00208	CcSEcCtD
Albendazole—Body temperature increased—Doxorubicin—sarcoma	0.000198	0.00208	CcSEcCtD
Albendazole—Hypersensitivity—Doxorubicin—sarcoma	0.000185	0.00194	CcSEcCtD
Albendazole—Dizziness—Epirubicin—sarcoma	0.000179	0.00188	CcSEcCtD
Albendazole—ABCB1—lymph node—sarcoma	0.000179	0.00286	CbGeAlD
Albendazole—Vomiting—Epirubicin—sarcoma	0.000172	0.00181	CcSEcCtD
Albendazole—Rash—Epirubicin—sarcoma	0.000171	0.00179	CcSEcCtD
Albendazole—Dermatitis—Epirubicin—sarcoma	0.000171	0.00179	CcSEcCtD
Albendazole—Headache—Epirubicin—sarcoma	0.00017	0.00178	CcSEcCtD
Albendazole—Dizziness—Doxorubicin—sarcoma	0.000166	0.00174	CcSEcCtD
Albendazole—Nausea—Epirubicin—sarcoma	0.000161	0.00169	CcSEcCtD
Albendazole—Vomiting—Doxorubicin—sarcoma	0.000159	0.00167	CcSEcCtD
Albendazole—Rash—Doxorubicin—sarcoma	0.000158	0.00166	CcSEcCtD
Albendazole—Dermatitis—Doxorubicin—sarcoma	0.000158	0.00166	CcSEcCtD
Albendazole—Headache—Doxorubicin—sarcoma	0.000157	0.00165	CcSEcCtD
Albendazole—Nausea—Doxorubicin—sarcoma	0.000149	0.00156	CcSEcCtD
